Use of sulfonamide carbonic anhydrase inhibitors in treatment of meningococcal carriers: rationale and report of a clinical trial of ethoxzolamide. [electronic resource]
- The American journal of the medical sciences Nov 1967
- 709-16 p. digital
Publication Type: Journal Article
0002-9629
10.1097/00000441-196711000-00017 doi
Carbonic Anhydrase Inhibitors--therapeutic use Carrier State--drug therapy Humans In Vitro Techniques Meningococcal Infections--drug therapy Neisseria meningitidis--drug effects Sulfadiazine--pharmacology Sulfonamides--pharmacology